These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1722609)

  • 1. Membranous lipodystrophy (Nasu-Hakola disease) with thalamic degeneration: report of an autopsied case.
    Miyazu K; Kobayashi K; Fukutani Y; Nakamura I; Hasegawa H; Yamaguchi N; Saitoh T
    Acta Neuropathol; 1991; 82(5):414-9. PubMed ID: 1722609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology.
    Kaneko M; Sano K; Nakayama J; Amano N
    Neuropathology; 2010 Oct; 30(5):463-70. PubMed ID: 20500450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerosing leucoencephalopathy with membranocystic lesions of adipose tissue: a contribution to the pathology of Nasu disease.
    Koizumi T; Matsubara R; Kurachi M; Isaki K; Yamaguchi N; Nakanuma Y
    Folia Psychiatr Neurol Jpn; 1982; 36(4):409-16. PubMed ID: 7169200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An autopsy case of membranous lipodystrophy (Nasu)].
    Takeshima M; Hitomi H; Kimura M; Doi K; Hamaya K
    No To Shinkei; 1984 Oct; 36(10):975-82. PubMed ID: 6518128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter lesions in Nasu-Hakola disease: a report on three autopsy cases.
    Aoki N; Tsuchiya K; Togo T; Kobayashi Z; Uchikado H; Katsuse O; Suzuki K; Fujishiro H; Arai T; Iseki E; Anno M; Kosaka K; Akiyama H; Hirayasu Y
    Neuropathology; 2011 Apr; 31(2):135-43. PubMed ID: 20880319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasu-Hakola disease: a review of its leukoencephalopathic and membranolipodystrophic features.
    Tanaka J
    Neuropathology; 2000 Sep; 20 Suppl():S25-9. PubMed ID: 11037183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous lipodystrophy presenting with palilalia: a PET study of cerebral glucose metabolism.
    Ueki Y; Kohara N; Oga T; Fukuyama H; Akiguchi I; Kimura J; Shibasaki H
    Acta Neurol Scand; 2000 Jul; 102(1):60-4. PubMed ID: 10893065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of membranous lipodystrophy (Nasu) with diffuse cerebral white matter involvement and cerebellar atrophy on brain CT and MRI].
    Shibata K; Uchiyama S; Takeuchi M; Kobayashi I; Maruyama S
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1232-7. PubMed ID: 2085928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukoencephalopathic alteration in membranous lipodystrophy.
    Tanaka J
    Acta Neuropathol; 1980; 50(3):193-7. PubMed ID: 7415812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasu-Hakola's disease (membranous lipodystrophy). A case report.
    Matsushita M; Oyanagi S; Hanawa S; Shiraki H; Kosaka K
    Acta Neuropathol; 1981; 54(2):89-93. PubMed ID: 7246060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasu-Hakola's disease (membranous lipodystrophy).
    Amano N; Iwabuchi K; Sakai H; Yagishita S; Itoh Y; Iseki E; Yokoi S; Arai N; Kinoshita J
    Acta Neuropathol; 1987; 74(3):294-9. PubMed ID: 3673522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation.
    Solje E; Hartikainen P; Valori M; Vanninen R; Tiihonen J; Hakola P; Tienari PJ; Remes AM
    Neurobiol Aging; 2014 Jul; 35(7):1780.e13-7. PubMed ID: 24612676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
    Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
    Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.
    Satoh J; Kino Y; Motohashi N; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
    Neuropathology; 2015 Dec; 35(6):529-37. PubMed ID: 26087043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid chemical study of an autopsy case of Nasu-Hakola disease].
    Yokoi S; Suzuki K; Amano N; Yagishita S
    No To Shinkei; 1988 Feb; 40(2):141-7. PubMed ID: 3370166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains.
    Satoh J; Motohashi N; Kino Y; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
    Orphanet J Rare Dis; 2014 May; 9():68. PubMed ID: 24886140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated Syk expression is enhanced in Nasu-Hakola disease brains.
    Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Saito Y; Arima K
    Neuropathology; 2012 Apr; 32(2):149-57. PubMed ID: 21981270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of "membranous lipodystrophy (Nasu)" with emphasis on psychiatric and neuropathologic aspects (author's transl)].
    Harada K
    Folia Psychiatr Neurol Jpn; 1975; 29(2):169-77. PubMed ID: 1176071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging findings of Nasu-Hakola disease: a case report.
    Kilic SA; Oner AY; Yuce C; Ozlu IC
    Clin Imaging; 2012; 36(6):877-80. PubMed ID: 23154029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
    Satoh J
    Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.